TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism
Maria I. New(University of Oxford), Nicholas B. La Thangue(University of Oxford)
Cited by 44
Related Papers
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
|Immunology and Cell Biology|2011|443
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
|Nature Communications|2023|115
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity
|Communications Biology|2023|16